Related Experiment Video
Updated: Jul 8, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Restoration of Dysferlin After Exon 32 Skipping in Patient Cells
Florian Barthélémy1,2, Sébastien Courrier3, Marc Bartoli4
1Microbiology Immunology and Molecular Genetics, University of California Los Angeles, Los Angeles, CA, USA.
Abstract:
Dysferlinopathies stand as uncommon genetic disorders that impact muscle function, stemming from mutations within the DYSF gene. Recent research has unveiled that exon 32 of DYSF is dispensable for dysferlin's functional properties. In this study, we introduce an approach to observe exon 32 skipping at both the RNA and protein levels, using an antisense oligonucleotide, within cells obtained from a patient affected with dysferlinopathy.
More Related Videos
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Satellite Stem Cells and Muscular Dystrophy

